Tag Archives: treatment

Veterans benefit from pain treatment without drugs

A new study finds a lower risk of adverse post-treatment outcomes among returning military service personnel with chronic pain who received nondrug therapy. Share on PinterestNew research shows that some nondrug therapies, including exercise therapy, can help relieve pain in veterans. Many people returning from military deployment experience physical and mental health issues. These can… Read More »

FDA Approves Isturisa (osilodrostat) for the Treatment of Cushing’s Disease

FDA Approves Isturisa (osilodrostat) for the Treatment of Cushing’s Disease Print this page March 06, 2020 — The U.S. Food and Drug Administration today approved Isturisa (osilodrostat) oral tablets for adults with Cushing’s disease who either cannot undergo pituitary gland surgery or have undergone the surgery but still have the disease. Cushing’s disease is a… Read More »

FDA Approves Ofev (Nintedanib), For The Treatment of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype

FDA Approves Ofev (Nintedanib), For The Treatment of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype Print this page March 09, 2020 — The U.S. Food and Drug Administration today approved Ofev (nintedanib) oral capsules to treat patients with chronic fibrosing (scarring) interstitial lung diseases (ILD) with a progressive phenotype (trait). It is the… Read More »

FDA Approves Nurtec ODT (rimegepant) for the Acute Treatment of Migraine in Adults

FDA Approves Nurtec ODT (rimegepant) for the Acute Treatment of Migraine in Adults Print this page NEW HAVEN, Conn., Feb. 27, 2020 /PRNewswire/ — Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced that the U.S. Food and Drug Administration (FDA) has approved Nurtec ODT (rimegepant) for the acute treatment of migraine in adults. Nurtec… Read More »

FDA Approves Advil Dual Action (ibuprofen and acetaminophen) as an Over-the-Counter Pain Treatment

FDA Approves Advil Dual Action (ibuprofen and acetaminophen) as an Over-the-Counter Pain Treatment Print this page WARREN, N.J., Feb. 28, 2020 /PRNewswire/ — GlaxoSmithKline (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Advil Dual Action with Acetaminophen as an over-the-counter (OTC) product for pain relief. The exclusive formula is now the first FDA-approved… Read More »